Mallinckrodt Facing $93M Drug Royalty Claim In Ch. 11
Drugmaker Mallinckrodt PLC was hit with more legal woes related to sales of its Acthar Gel infantile spasms drug Wednesday after three individuals filed a suit in Delaware bankruptcy court asserting...To view the full article, register now.
Already a subscriber? Click here to view full article